Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Effect of rejuvenation hormones on spermatogenesis

Review . 2013 Jun;99(7):1814-20. doi: 10.1016/j.fertnstert.2013.04.003. Epub 2013 May 10. Affiliations PMID: 23663992 DOI: 10.1016/j.fertnstert.2013.04.003 Free article Review Effect of rejuvenation hormones on spermatogenesis Jared L Moss et al. Fertil Steril. 2013 Jun. Free article Abstract Objective: To review the current literature for the effect of hormones used in rejuvenation clinics on the maintenance of spermatogenesis. Design: Review of published literature. Setting: Not applicable. Patient(s): Men who have undergone exogenous testosterone (T) and/or anabolic androgenic steroid (AAS) therapies. Intervention(s): None. Main outcome measure(s): Semen analysis, pregnancy outcomes, and time to recovery of spermatogenesis. Result(s): Exogenous testosterone and anabolic androgenic steroids suppress intratesticular testosterone production, which may lead to azoospermia or severe oligozoospermia. Therapies that protect spermatogenesis involve human chorionic gonadotropin (hCG) therapy

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Review

. 2013 Jun;99(7):1814-20.

doi: 10.1016/j.fertnstert.2013.04.003. Epub 2013 May 10.

Affiliations

PMID: 23663992 DOI: 10.1016/j.fertnstert.2013.04.003

Free article

Review

Effect of rejuvenation hormones on spermatogenesis

Jared L Moss et al. Fertil Steril. 2013 Jun.

Free article

Abstract

Objective: To review the current literature for the effect of hormones used in rejuvenation clinics on the maintenance of spermatogenesis.

Design: Review of published literature.

Setting: Not applicable.

Patient(s): Men who have undergone exogenous testosterone (T) and/or anabolic androgenic steroid (AAS) therapies.

Intervention(s): None.

Main outcome measure(s): Semen analysis, pregnancy outcomes, and time to recovery of spermatogenesis.

Result(s): Exogenous testosterone and anabolic androgenic steroids suppress intratesticular testosterone production, which may lead to azoospermia or severe oligozoospermia. Therapies that protect spermatogenesis involve human chorionic gonadotropin (hCG) therapy and selective estrogen receptor modulators (SERMs). The studies examining the effect of human growth hormone (HGH) on infertile men are uncontrolled and unconvincing, but they do not appear to negatively impact spermatogenesis. At present, routine use of aromatase inhibitors is not recommended based on a lack of long-term data.

Conclusion(s): The use of hormones for rejuvenation is increasing with the aging of the Baby Boomer population. Men desiring children at a later age may be unaware of the side-effect profile of hormones used at rejuvenation centers. Testosterone and anabolic androgenic steroids have well-established detrimental effects on spermatogenesis, but recovery may be possible with cessation. Clomiphene citrate, human growth hormone (HGH)/insulin-like growth factor-1 (IGF-1), human chorionic gonadotropin (hCG), and aromatase inhibitors do not appear to have significant negative effects on sperm production, but quality data are lacking.

Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Comment in

Word of wisdom. Re: effect of rejuvenation hormones on spermatogenesis.

Howards SS, Schlegel PN. Howards SS, et al. Eur Urol. 2014 Oct;66(4):788-9. doi: 10.1016/j.eururo.2014.07.052. Eur Urol. 2014. PMID: 25218076 No abstract available.

Connected topics

Follow this recovery question